The rapid alert system on for food and feed - Annual report 2012 on the

Nanobiotechnological applications in the medical area belong to the most advanced and promising fields. As the field of nanobiotechnology is rather young, a comprehensive picture of the state-of-the-art of research and commercial nanobiotechnology activities in Europe is still missing. Furthermore, to enable the exploitation of this technology and a proactive approach to increase European competitiveness, information is needed on future directions of nanobiotechnology applications and on possible drivers and barriers for its development.

The first scientific opinion on the safe use of titanium dioxide as a UV-filter at a maximum concentration of 25% in cosmetic products was adopted 24 October 2000 by the SCCNFP (SCCNFP/0005/98).

This publication describes the unique nature of nanotechnology, bringing innovation to every aspect of human existence. The publication outlines nanoscience and nanotechnology dedicated research expenditure in Europe over recent years, in particular via the 7th research framework programme (FP7). An overview is given of the main sectors where nanotechnology is enabling significant progress. It highlights a selection of exemplary projects financed through FP7 that are representative of major research themes, such as nanoelectronics, nanophotonics, nanobiotechnology, nanomedicine, self-assembly, catalysts, industrial applications, energy and environment, tools for investing the nanoscale, health/safety/environment and communication/societal impact.